Key Points
- CFO Girish Satya sold 41,662 shares on March 25 at an average price of $1.18, cutting his stake by 11.27% to 327,909 shares valued at roughly $386,933, according to the SEC filing.
- Zevia shares are weak—down 3.8% and trading near $1.13 with a 12‑month range of $1.11–$3.66 and a market cap of about $84.5M; the company beat EPS (-$0.02 vs. -$0.03) but missed revenue and still reports negative margins and ROE.
- Analyst and institutional signals are mixed: the consensus rating is a Hold with an average target of $4.43, while hedge funds have been adding positions and institutions own roughly 53.2% of the stock.
Zevia PBC (NYSE:ZVIA - Get Free Report) CFO Girish Satya sold 41,662 shares of Zevia PBC stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of $1.18, for a total transaction of $49,161.16. Following the completion of the sale, the chief financial officer directly owned 327,909 shares in the company, valued at approximately $386,932.62. This represents a 11.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Zevia PBC Stock Down 3.8%
Zevia PBC stock opened at $1.13 on Friday. Zevia PBC has a twelve month low of $1.11 and a twelve month high of $3.66. The firm has a 50 day moving average price of $1.55 and a 200-day moving average price of $2.11. The company has a market capitalization of $84.49 million, a P/E ratio of -7.50 and a beta of 0.90.
Zevia PBC (NYSE:ZVIA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.01. Zevia PBC had a negative net margin of 6.15% and a negative return on equity of 22.49%. The company had revenue of $37.87 million for the quarter, compared to analysts' expectations of $39.96 million. Equities analysts expect that Zevia PBC will post -0.32 EPS for the current fiscal year.
Analyst Ratings Changes
ZVIA has been the topic of several research reports. Craig Hallum initiated coverage on Zevia PBC in a research note on Thursday, January 15th. They issued a "buy" rating and a $4.00 target price on the stock. Telsey Advisory Group decreased their price objective on Zevia PBC from $6.00 to $5.00 and set an "outperform" rating for the company in a report on Thursday, February 26th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Zevia PBC in a research note on Wednesday, January 21st. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Zevia PBC currently has a consensus rating of "Hold" and an average target price of $4.43.
Get Our Latest Stock Analysis on Zevia PBC
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. Divisadero Street Capital Management LP bought a new stake in Zevia PBC during the 2nd quarter valued at $10,404,000. Jefferies Financial Group Inc. bought a new position in shares of Zevia PBC in the fourth quarter worth $4,864,000. Ghisallo Capital Management LLC grew its position in shares of Zevia PBC by 265.1% in the third quarter. Ghisallo Capital Management LLC now owns 1,100,000 shares of the company's stock valued at $2,992,000 after purchasing an additional 798,700 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of Zevia PBC by 382.1% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 527,498 shares of the company's stock valued at $1,224,000 after purchasing an additional 418,077 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Zevia PBC by 66.5% during the 2nd quarter. Geode Capital Management LLC now owns 933,407 shares of the company's stock valued at $3,006,000 after purchasing an additional 372,665 shares during the period. 53.21% of the stock is currently owned by hedge funds and other institutional investors.
About Zevia PBC
(
Get Free Report)
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia's mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company's product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
